NJTC Venture Fund
Tech Council Ventures (TCV) is a venture firm that invests in early-stage technology companies in the Mid-Atlantic region. With $175M assets under management, the firm provides Seed and Series A financing (typical check sizes $500K–$3M) and offers portfolio support through its network aligned with TechUnited/technology council resources.
NJTC Venture Fund
Mount Laurel, New Jersey, United States, North America
Services
Equity investments (Seed and Series A)
Direct early-stage capital with typical investment sizes described as $500,000 to $3,000,000.
Strategic guidance and mentorship
Ongoing advisory support from the firm’s team and network, including subject-matter experts and investor judges who participate in panels and programs.
Access to TechUnited programs and network
Connections to TechUnited experiences and regional technology council resources for business development, education, networking, recognition, and advocacy.
Office Hours / Meet Our Experts
Regular expert sessions and office hours intended to provide hands-on support to entrepreneurs.
Equity investments (Seed and Series A)
Direct early-stage capital with typical investment sizes described as $500,000 to $3,000,000.
Strategic guidance and mentorship
Ongoing advisory support from the firm’s team and network, including subject-matter experts and investor judges who participate in panels and programs.
Access to TechUnited programs and network
Connections to TechUnited experiences and regional technology council resources for business development, education, networking, recognition, and advocacy.
Office Hours / Meet Our Experts
Regular expert sessions and office hours intended to provide hands-on support to entrepreneurs.
Portfolio
Recognized on CB Insights Digital Health 150 (2022); featured in Penn Medicine press release; CEO Subha Airan-Javia received a Sharp Index Award.
#Digital health / care coordination
Attained SOC 2 Type 2 compliance; ranked on the Inc. 5000 list (No.1 among private software companies in 2022); recipient of industry awards.
#Software / data analytics for pharmacy benefits
Received a $1.67M NIH NIAMS Phase II SBIR grant to develop a disease-modifying osteoarthritis drug.
#Biopharmaceuticals / therapeutics
Announced investment from Tech Council Ventures; later merged with Upgraid to expand position in clinical nutrition.
#Clinical nutrition / Food-as-Medicine
Featured in coverage of printed thin-film battery research and prototype testing.
#Energy / printed batteries / IoT
Recognized on CB Insights Digital Health 150 (2022); featured in Penn Medicine press release; CEO Subha Airan-Javia received a Sharp Index Award.
#Digital health / care coordination
Attained SOC 2 Type 2 compliance; ranked on the Inc. 5000 list (No.1 among private software companies in 2022); recipient of industry awards.
#Software / data analytics for pharmacy benefits
Received a $1.67M NIH NIAMS Phase II SBIR grant to develop a disease-modifying osteoarthritis drug.
#Biopharmaceuticals / therapeutics
Announced investment from Tech Council Ventures; later merged with Upgraid to expand position in clinical nutrition.
#Clinical nutrition / Food-as-Medicine
Featured in coverage of printed thin-film battery research and prototype testing.
#Energy / printed batteries / IoT